Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Synthetic Stem Cells Market - Global Forecast to 2028 - ResearchAndMarkets.com

Research and Markets
Posted on: 12 Dec 18

The "Synthetic Stem Cells Market by Application, Region - Global Forecast to 2028" report has been added to ResearchAndMarkets.com's offering.

Ethical concerns regarding embryonic stem cells is expected to drive the overall growth of the synthetic stem cells market.

The synthetic stem cells market is expected to grow from USD 14 million in 2023 to USD 37 million by 2028, at a CAGR of 22.5% during the forecast period.

The synthetic stem cells market is driven by various factors such as ethical concerns regarding embryonic stem cells and the risk of tumor formation and immune rejection of natural stem cells. However, the unclear and unstructured regulations on the use of synthetic stem cells can hinder the growth of the market.

The neurological disorders application is the faster-growing segment in the overall synthetic stem cells market. Based on application, the synthetic stem cells market is segmented into cardiovascular diseases, neurological disorders, and other diseases that include various cancers, wounds and injuries, musculoskeletal disorders, and blood disorders that require regenerative therapies.

Countries in North America are constantly modernizing their healthcare infrastructure by investing in advanced therapies. The increasing prevalence of target diseases, focus on development of for regenerative medicines, fast adoption of advanced therapies, and regulatory support for stem cell therapies will result in the high rate of adoption of synthetic stem cell therapies in this region by 2023.

The synthetic stem cells market comprises two major providers, namely, North Carolina State University (NCSU) (US) and Zhengzhou University (China).

Market Dynamics

Market Drivers

  • Ethical Concerns Regarding Embryonic Stem Cells
  • Risk of Tumor Formation and Immune Rejection of Natural Stem Cells

Market Restraints

  • Unclear and Unstructured Regulations

Market Opportunities

  • Costly Storage and Fragility of Natural Stem Cells
  • Potential Application in Major Indications
  • Increasing Stem Cell Research Funding

For more information about this report visit https://www.researchandmarkets.com/research/q85cfr/synthetic_stem?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20181212005561/en/

Business Wire
www.businesswire.com

Last updated on: 12/12/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.